Loading verified market, valuation, and statement data.
2. Company Fundamentals
2.1 Competitiveness
| Metric |
Value |
| Operating Margins |
5.58% |
| Profit Margins |
17.33% |
| Return on Equity |
34.79% |
| Return on Assets |
2.75% |
| Free Float |
0.15B |
| Short Int % Utilisation |
5.15% |
2.2 Growth
| Metric |
Value |
| Revenue Growth |
-3.0% |
| Free Cash Flow |
0.38B |
| EBITDA |
16.68 (Ratio) |
| Enterprise Value |
18.75B |
| EV/Revenue |
2.27 |
| EV/EBITDA |
16.68 |
Revenue growth of -3.0% suggests mature or challenged top-line momentum.
2.3 Management
| Role |
Metric |
| Consensus Rating |
N/A |
2.4 Return
| Metric |
Value |
| Expected Return (Ann.)* |
30.07% |
| Risk / Std Dev (Ann.)* |
30.10% |
| 1-Year Price Return* |
24.04% |
Latest Market Data (as of 2026-08-14, US Eastern time):
| Metric |
Value |
| Last Price |
$88.59 |
| 52-Week Range |
$62.38 – $90.00 |
| Observation Count |
250 trading days |
The return and risk statistics use daily adjusted closes from the retrieved one-year series and annualise daily moments using 252 trading days. The last price is the latest regular-market price reported for the stated date. Source: Yahoo Finance market data.
2.5 FCFF DCF Valuation
Valuation basis: This research model follows a five-year, unlevered FCFF DCF. It starts from reported annual operating inputs, forecasts revenue and operating cash conversion under an explicit mechanical policy, discounts FCFF at WACC, applies a Gordon-growth terminal value, and bridges enterprise value to an indicative common-equity value per share. It is an analytical estimate rather than a recommendation or personalised target price.
Step 1 — Forecast Operating Profit and NOPAT
| Reported operating input |
Value |
| Revenue |
$8.32B |
| Prior annual revenue |
$8.25B |
| EBIT |
$2.06B |
| Tax rate |
9.17% |
| NOPAT = EBIT × (1 − tax rate) |
$1.87B |
| Forecast start-growth basis |
0.86% |
| Forecast policy |
latest reported annual revenue growth, bounded to -10.00% / 15.00% |
Step 2 — Calculate FCFF
| Current FCFF building block |
Value |
| NOPAT |
$1.87B |
| Add: depreciation & amortisation |
$489.00M |
| Less: capital expenditure |
-$379.00M |
| Less/(add): working-capital cash-flow movement |
-$119.00M |
| Current unlevered FCFF |
$1.86B |
Explicit FCFF forecast
| Forecast year |
Revenue growth |
NOPAT |
D&A |
Capex |
Change in NWC |
FCFF |
Present value |
| 1 |
0.86% |
$1.89B |
$493.21M |
-$382.26M |
-$120.02M |
$1.88B |
$1.81B |
| 2 |
1.27% |
$1.91B |
$499.47M |
-$415.20M |
-$121.55M |
$1.87B |
$1.68B |
| 3 |
1.68% |
$1.94B |
$507.86M |
-$450.74M |
-$123.59M |
$1.88B |
$1.57B |
| 4 |
2.09% |
$1.98B |
$518.48M |
-$489.32M |
-$126.17M |
$1.89B |
$1.46B |
| 5 |
2.50% |
$2.03B |
$531.44M |
-$531.44M |
-$129.33M |
$1.90B |
$1.38B |
Step 3 — Determine the Discount Rate (WACC)
| WACC input |
Value |
| Risk-free rate |
4.71% |
| Equity risk premium assumption |
5.50% |
| Beta |
0.67 |
| Cost of equity |
8.40% |
| Pre-tax cost of debt |
5.32% |
| WACC |
7.50% |
| WACC validation |
within standard range |
Step 4 — Estimate Terminal Value
| Terminal-value input |
Value |
| Perpetuity growth rate |
2.50% |
| Terminal value |
$39.01B |
| Implied terminal EV / EBITDA |
14.08x |
| Terminal value as % of enterprise value |
77.47% |
Step 5 — Discount Cash Flows to Enterprise Value
| Enterprise-value component |
Value |
| Present value of explicit FCFF |
$7.90B |
| Present value of terminal value |
$27.17B |
| Indicated enterprise value |
$35.06B |
| Discounting convention |
mid-year for explicit FCFF; terminal value discounted at year-end five |
Step 6 — Convert Enterprise Value to Equity Value
| Equity bridge |
Value |
| Indicated enterprise value |
$35.06B |
| Less: gross interest-bearing debt |
$5.04B |
| Add: cash and equivalents |
$878.00M |
| Add: affiliate investments |
$0.00 |
| Less: minority interests |
$0.00 |
| Indicated common equity value |
$30.91B |
Step 7 — Calculate Indicative Value Per Share
| Per-share output |
Value |
| Shares used |
175,300,000.00 |
| Share-count basis |
reported diluted weighted-average shares |
| Current market price |
$87.93 |
| DCF indicative value per share |
$176.31 |
| Indicative value vs. market price |
100.50% |
Model Integrity Checks
| Check |
Result |
| Perpetuity growth is below the risk-free rate |
pass |
| Perpetuity growth is below WACC |
pass |
| WACC is within the configured operating-company range |
pass |
| Terminal-year FCFF is positive |
pass |
| Terminal capex converges to D&A |
pass |
| Terminal-value concentration |
within review band |
| Implied price differs from spot by more than 30% |
review required |
2.6 Investor-Style Research Screen
| Educational screen |
Result |
| Buffett-inspired cash-quality checks |
2/4 evidenced checks |
| Lynch-inspired balance-and-growth checks |
2/4 evidenced checks |